Cleveland-based Marconi Medical Systems announced the promotion of Karl Wolcott to vice president and general manager of Marconi’s Picker Health Care Products business. He replaces Jerry C. Sirino, who was recently promoted to executive vice
Cleveland-based Marconi Medical Systems announced the promotion of Karl Wolcott to vice president and general manager of Marconis Picker Health Care Products business. He replaces Jerry C. Sirino, who was recently promoted to executive vice president of global sales and service for Marconi.
Wolcott began his career 14 years ago with what is now Marconi. He was previously vice president of field operations, where he managed distribution, service, technical programs, sales, and group accounts. In his new position, he will focus on developing new products and services and e-commerce.
Marconi Medical Systems is organized into three businesses: Picker Medical Imaging, which combines the companys imaging systems, services, financing, and sales operations worldwide; Picker Information Management; a full-line provider of PACS solutions including teleradiology, centralized reading, and filmless radiology; and Picker Health Care Products, which distributes radiology equipment and other hospital supplies.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
Study: Abbreviated Breast MRI Offers Equivalent Accuracy to mpMRI for Women with Dense Breasts
May 20th 2025Emerging research suggests that abbreviated breast MRI offers comparable sensitivity and specificity as multiparametric MRI in women with extremely dense breasts with a nearly 50 percent reduction in reading time for radiologists.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.